Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases-Reference-Cited by-同舟云学术

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases

Published:2016-07-07 Issue:31 Volume:7 Page:50461-50476
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sommer Ann-Katrin¹²,Hermawan Adam¹,Mickler Frauke Martina³,Ljepoja Bojan¹,Knyazev Pjotr²,Bräuchle Christoph³,Ullrich Axel²,Wagner Ernst¹,Roidl Andreas¹

Affiliation:

1. Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany

2. Department of Molecular Biology, Max-Planck-Institute of Biochemistry, 82152 Martinsried, Germany

3. Physical Chemistry, Department of Chemistry, Ludwig-Maximilians-Universität München, 81377 Munich, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reductive stress and cytotoxicity in the swollen river mussel (Unio tumidus) exposed to microplastics and salinomycin;Environmental Pollution;2024-06

2. Reductive stress and apoptotic activities in bivalve mollusc Unio tumidus exposed to the combination of microplastics, antibiotic salinomycin and heating;2023-07-11

3. Combined effect of microplastic, salinomycin and heating on Unio tumidus;Environmental Toxicology and Pharmacology;2023-03

4. Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen;Frontiers in Oncology;2022-12-19

5. QUALITY BY DESIGN APPROACH FOR THE DEVELOPMENT OF SALINOMYCIN AND GEMCITABINE COMBINATION THERAPY LIPOSOMES FOR COLORECTAL CANCER;FARMACIA;2022-06-26